ReviewCellular & molecular biology letters2022
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.
Mostafa Vaghari-Tabari et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled itcites it